Combating Illicit Xylazine Act
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
The Combating Illicit Xylazine Act places xylazine, an animal sedative increasingly diverted for illicit human use, into Schedule III of the Controlled Substances Act. The bill restricts legitimate possession to veterinarians, pharmacies dispensing under veterinary prescription, and authorized animal-control and wildlife programs, while exempting existing manufacturers from certain security requirements and providing transition periods for compliance. It also requires the DEA and FDA to track xylazine distribution, directs the Sentencing Commission to establish appropriate penalties for xylazine trafficking offenses, and mandates reports to Congress on xylazine diversion and misuse.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.